SNAP-8 (Acetyl Octapeptide-3) vs Thymalin
A neutral, side-by-side comparison of two anti-aging & longevity peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
SNAP-8 (Acetyl Octapeptide-3)
8-amino acid cosmetic peptide active (Acetyl Octapeptide-3) that competes with SNARE complex proteins to reduce neuromuscular signal transmission in facial expression muscles. An extended, more potent version of Argireline (Acetyl Hexapeptide-3). Clinical studies show 26–63% reduction in expression wrinkle depth with twice-daily application, positioning it as a topical botulinum toxin alternative.
Full profileThymalin
Thymus-derived peptide bioregulator developed in Russia containing a mixture of low-molecular-weight peptides extracted from calf thymus. Primarily studied for reversing immunological aging (immunosenescence) and extending healthy lifespan. Vladimir Khavinson's longitudinal research on elderly patients links thymalin administration to significant improvements in immune markers and all-cause mortality reduction.
Full profile| SNAP-8 (Acetyl Octapeptide-3) | Thymalin | |
|---|---|---|
| Category | Anti-Aging & Longevity | Anti-Aging & Longevity |
| Also known as | Leuphasyl, Acetyl Octapeptide-3, SNAP-8 peptide, Argireline extension, Acetyl Glutamyl Heptapeptide-3 | thymic peptide bioregulator, T-activin extract, thymus peptide, thymic bioregulator |
| Evidence | Research-stage | Research-stage |
| Dosing range | 1%–10% %, twice daily topical application | 5mg–20mg mg, 5–10 day course, 1–2x per year |
| Administration | Topical (serum/cream) | Intramuscular injection, Subcutaneous injection |
| Key side effects | Very well-tolerated, Rare mild skin irritation or redness, No systemic absorption at cosmetic concentrations, No paralysis risk (partial SNARE competition only) | Injection site reactions, Mild fever (rare), Temporary increase in immune activity (desired response), Rare hypersensitivity |
| Cited sources | 2 references | 2 references |
Key differences
- Administration: SNAP-8 (Acetyl Octapeptide-3) — Topical (serum/cream); Thymalin — Intramuscular injection, Subcutaneous injection.
- Dosing units differ: SNAP-8 (Acetyl Octapeptide-3) is dosed in %, Thymalin in mg — they operate at different scales.
- Frequency: SNAP-8 (Acetyl Octapeptide-3) is typically twice daily topical application; Thymalin is 5–10 day course, 1–2x per year.
How each works
SNAP-8 (Acetyl Octapeptide-3)
SNAP-8 mimics the N-terminal domain of SNAP-25, competing for SNARE complex assembly required for acetylcholine vesicle fusion at the neuromuscular junction. This partial inhibition reduces muscle contraction intensity without complete paralysis. Clinical studies demonstrate statistically significant reductions in crow's feet and forehead line depth after 28 days of use at 5–10% concentration.
Thymalin
Thymalin contains multiple bioactive peptides that stimulate T-lymphocyte differentiation and restore thymic function that declines with age. In Khavinson's 6-year controlled trial of elderly patients (78–89 years), annual thymalin courses were associated with significantly lower mortality and improved immune parameters vs. controls. Proposed mechanisms include telomerase activation in immune cells and restoration of thymic epithelial cell function.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.